The women were classified into those with ( n = 72 ) and without ( n = 78 ) hot flashes and treated for 6 months with transdermal estradiol ( 1 mg/d ) , oral estradiol ( 2 mg/d ) with or without medroxyprogesterone acetate ( 5 mg/d ) , or placebo .